Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1996
08/29/1996WO1996026195A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996WO1996026187A1 Fibrinogen receptor antagonists
08/29/1996WO1996026183A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
08/29/1996WO1996026180A1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals
08/29/1996WO1996025956A2 Individual medicament dosing conjugate
08/29/1996WO1996025949A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
08/29/1996WO1996025948A1 PREPARATION AND USE OF A SPECIFIC GABA-Aα5 RECEPTOR LIGAND FOR TREATMENT OF ALZHEIMER'S DISEASE
08/29/1996WO1996025942A1 Cochleate phospholipids in drug delivery
08/29/1996WO1996025940A1 Composition for the treatment of diarrhea, its use and its preparation
08/29/1996WO1996025937A1 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis
08/29/1996WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996WO1996025935A1 Method of treating adenosine depletion
08/29/1996WO1996025933A2 Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks
08/29/1996WO1996025932A1 Preventive/remedy for interstitial pneumonia, inflammatory intestinal diseases or vascular thickening containing quinolizinone compounds, salt thereof or hydrates therefor
08/29/1996WO1996025931A2 Use of fused benzothiazoles as neuroprotectants
08/29/1996WO1996025929A1 Use of helioxanthin as an enhancer of cell differentiation inducing factors
08/29/1996WO1996025928A1 Method of use of radicicol for treatment of inflammation and endotoxemia
08/29/1996WO1996025926A1 Glutamic acid receptor agonist
08/29/1996WO1996025925A1 Nasal and ocular administration of ketamine to manage pain and for detoxification
08/29/1996WO1996025924A2 Use of fluorocarbon liquids for accelerating lung and other tissue growth
08/29/1996WO1996025921A1 Polyalkylene block copolymers as surface modifiers for nanoparticles
08/29/1996WO1996025920A1 Cosmetic melanins
08/29/1996WO1996025919A1 Aerosols containing beclomethazone nanoparticle dispersions
08/29/1996WO1996025918A1 Aerosols containing nanoparticle dispersions
08/29/1996WO1996025915A1 Improved hemostatic composition for treating gingival area
08/29/1996WO1996025912A1 Method for topical treatment of scar tissue and related tissue reaction to trauma
08/29/1996WO1996025861A1 Amino acid compositions and use thereof in clinical nutrition
08/29/1996WO1996025859A1 Use of l-carnitine as a feed-additive for crustaceans
08/29/1996WO1996025852A1 Composition for controlling parasites
08/29/1996WO1996019580A3 Telomerase protein component
08/29/1996WO1996018406A3 Ophthalmic formulations of substituted glycosides
08/29/1996WO1996016675A3 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors
08/29/1996WO1996015791A3 Use of substituted aryl-morpholino-, thiomorpholino- or piperazino-propanones for the treatement of prevention of alzheimer'disease
08/29/1996DE19506669A1 Lipoxygenase inhibitor for treating asthma, tumours, shock etc.
08/29/1996CA2213710A1 Method for topical treatment of scar tissue and related tissue reaction to trauma
08/29/1996CA2213632A1 Method of use of radicicol for treatment of inflammation and endotoxemia
08/29/1996CA2213610A1 Ingap protein involved in pancreatic islet neogenesis
08/29/1996CA2213507A1 Pharmaceutical composition for treating transient ischemic attack
08/29/1996CA2213454A1 Dtpa derivatives substituted in a novel way, their metal complexes, pharmaceutical agents containing these complexes, their use in diagnosis and therapy, as well as process for the production of complexes and agents
08/29/1996CA2213439A1 Methods and compositions for administering gene therapy vectors
08/29/1996CA2213428A1 A method for the isolation and purification of lipid cell-wall components
08/29/1996CA2213408A1 Improved hemostatic composition for treating soft tissue
08/29/1996CA2213192A1 Alpha.1a. adrenergic receptor antagonists
08/29/1996CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2212870A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
08/29/1996CA2212829A1 Glutamic acid receptor agonist
08/29/1996CA2212525A1 Use of fused benzothiazoles as neuroprotectants
08/29/1996CA2212106A1 Composition for the treatment of diarrhea, its use and its preparation
08/29/1996CA2211890A1 Fibrinogen receptor antagonists
08/29/1996CA2211558A1 Use of fluorocarbon liquids for accelerating lung and other tissue growth
08/29/1996CA2211027A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996CA2210499A1 Amino acid compositions and use thereof in a clinical nutrition
08/29/1996CA2210320A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
08/29/1996CA2170480A1 Methods of inhibiting estrogen positive tumors of the brain or cns
08/29/1996CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods
08/29/1996CA2169414A1 Phosphorous-containing benzothiophenes
08/29/1996CA2167118A1 Enzymatic process for producing penicillins and cephalosporins
08/28/1996EP0728763A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor
08/28/1996EP0728759A1 Heterocyclic compounds
08/28/1996EP0728758A1 Dioxopyrrolo-pyrrole derivatives
08/28/1996EP0728755A1 Thiophene compounds, process for their preparation and pharmaceutical compositions containing them
08/28/1996EP0728752A1 Triazole compounds, their production and use
08/28/1996EP0728751A2 Process for the manufacture of diltiazem
08/28/1996EP0728747A1 Imidazole derivative, pharmaceutically acceptable salt thereof, process of manufacture therefor, and anti-ulcer drug including such derivative or salt
08/28/1996EP0728746A1 Azepinone compounds useful in the inhibition of ACE and NEP
08/28/1996EP0728742A2 Novel retinoids
08/28/1996EP0728741A1 Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them
08/28/1996EP0728739A1 Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations
08/28/1996EP0728738A1 Tetralinyl- and indanyl-ethylamides having melatonergic activity
08/28/1996EP0728483A1 Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
08/28/1996EP0728482A2 Use of hcp specific compounds to enhance erythropoiesis
08/28/1996EP0728481A2 Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections
08/28/1996EP0728480A1 Use of ifenprodil for treatment of elevated intraocular pressure
08/28/1996EP0728479A1 Deacetyl moxisylyte in the treatment of acute urinary retention
08/28/1996EP0728478A1 Antimicrobial method and cosmetic composition
08/28/1996EP0728477A2 Compositions for topical administration of pharmaceutically active agents
08/28/1996EP0728468A2 Cosmetic compositions for treating itchy skin
08/28/1996EP0728209A1 Endothelin-converting enzyme
08/28/1996EP0728205A1 Method and reagent for treatment of arthritic conditions
08/28/1996EP0728145A1 Endothelin receptor antagonists
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728140A1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
08/28/1996EP0728138A1 Anthracycline derivatives
08/28/1996EP0728136A1 N-substituted azabicycloalkane derivatives, their preparation and use
08/28/1996EP0728135A1 Urea derivatives
08/28/1996EP0728134A1 6-oxo-nucleosides useful as immunosuppressants
08/28/1996EP0728131A1 Novel taxoids, their preparation and pharmaceutical compositions containing them
08/28/1996EP0728130A1 Pyrimidine-thioalkyl and alkylether compounds
08/28/1996EP0728129A1 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
08/28/1996EP0728128A1 Substituted phenyl compounds
08/28/1996EP0728009A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
08/28/1996EP0728006A1 Use of mannose phosphates for the treatment of fibrotic disorders
08/28/1996EP0728005A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
08/28/1996EP0728004A1 Use of steroids with a phenolic a-ring structure for prophylaxis and therapy of radical-mediated cell damage
08/28/1996EP0728003A1 Method for preventing tissue injury from hypoxia
08/28/1996EP0728002A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
08/28/1996EP0728001A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
08/28/1996EP0728000A1 The use of alfuzosin or terazosin in the treatment of premature ejaculation
08/28/1996EP0727999A1 Treatment of immunoregulatory disorders
08/28/1996EP0727998A1 Oxazoles for treating cytokine mediated diseases
1 ... 6885 6886 6887 6888 6889 6890 6891 6892 6893 6894 6895 6896 6897 6898 6899 6900 6901 6902 6903 6904 6905 ... 7860